These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27561175)

  • 1. Effect of as-needed use of intranasal PH94B on social and performance anxiety in individuals with social anxiety disorder.
    Liebowitz MR; Hanover R; Draine A; Lemming R; Careri J; Monti L
    Depress Anxiety; 2016 Dec; 33(12):1081-1089. PubMed ID: 27561175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorder.
    Liebowitz MR; Salman E; Nicolini H; Rosenthal N; Hanover R; Monti L
    Am J Psychiatry; 2014 Jun; 171(6):675-82. PubMed ID: 24700254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan.
    Asakura S; Hayano T; Hagino A; Koyama T
    Curr Med Res Opin; 2016; 32(4):749-57. PubMed ID: 26808688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.
    Strawn JR; Compton SN; Robertson B; Albano AM; Hamdani M; Rynn MA
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):29-37. PubMed ID: 28165762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial.
    Taylor JH; Landeros-Weisenberger A; Coughlin C; Mulqueen J; Johnson JA; Gabriel D; Reed MO; Jakubovski E; Bloch MH
    Neuropsychopharmacology; 2018 Jan; 43(2):325-333. PubMed ID: 28849779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.
    Stein DJ; Westenberg HG; Yang H; Li D; Barbato LM
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):317-23. PubMed ID: 14604447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
    Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
    Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent class analysis of the feared situations of social anxiety disorder: A population-based study.
    Peyre H; Hoertel N; Rivollier F; Landman B; McMahon K; Chevance A; Lemogne C; Delorme R; Blanco C; Limosin F
    Depress Anxiety; 2016 Dec; 33(12):1178-1187. PubMed ID: 27575056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
    Danforth AL; Grob CS; Struble C; Feduccia AA; Walker N; Jerome L; Yazar-Klosinski B; Emerson A
    Psychopharmacology (Berl); 2018 Nov; 235(11):3137-3148. PubMed ID: 30196397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
    Pollack MH; Van Ameringen M; Simon NM; Worthington JW; Hoge EA; Keshaviah A; Stein MB
    Am J Psychiatry; 2014 Jan; 171(1):44-53. PubMed ID: 24399428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
    Vaishnavi S; Alamy S; Zhang W; Connor KM; Davidson JR
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1464-9. PubMed ID: 17698275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study.
    Schmidt ME; Liebowitz MR; Stein MB; Grunfeld J; Van Hove I; Simmons WK; Van Der Ark P; Palmer JA; Saad ZS; Pemberton DJ; Van Nueten L; Drevets WC
    Neuropsychopharmacology; 2021 Apr; 46(5):1004-1010. PubMed ID: 33070154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study.
    Asakura S; Tajima O; Koyama T
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):263-74. PubMed ID: 16573847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of olanzapine in social anxiety disorder: a pilot study.
    Barnett SD; Kramer ML; Casat CD; Connor KM; Davidson JR
    J Psychopharmacol; 2002 Dec; 16(4):365-8. PubMed ID: 12503837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. School-based behavioral treatment for social anxiety disorder in adolescents: results of a pilot study.
    Masia CL; Klein RG; Storch EA; Corda B
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):780-6. PubMed ID: 11437016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.
    Greist JH; Liu-Dumaw M; Schweizer E; Feltner D
    Int Clin Psychopharmacol; 2011 Sep; 26(5):243-51. PubMed ID: 21734588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
    Roque AD; Rosenfield D; Smits JAJ; Simon N; Otto MW; Marques L; Pollack MH; Hofmann SG; Meuret AE
    J Anxiety Disord; 2018 Jan; 53():85-90. PubMed ID: 29227845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder.
    Careri JM; Draine AE; Hanover R; Liebowitz MR
    Prim Care Companion CNS Disord; 2015; 17(6):. PubMed ID: 27057414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia].
    Bobes J; Badía X; Luque A; García M; González MP; Dal-Ré R
    Med Clin (Barc); 1999 Apr; 112(14):530-8. PubMed ID: 10363239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.